Coverage
-
August 04, 2023
The Judicial Panel of Multidistrict Litigation has sent five state cases against insulin manufacturers such as Eli Lilly and pharmacy benefit managers including CVS to the District of New Jersey, ruling the district will allow for efficient pretrial proceedings.
2 other articles on this case.
View all »